Melanie M Hagleitner

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. pmc Survival trends and long-term toxicity in pediatric patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
    Sarcoma 2012:636405. 2012
  2. doi request reprint Age as prognostic factor in patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, 6500HB Nijmegen, The Netherlands
    Bone 49:1173-7. 2011
  3. doi request reprint Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Pediatr Blood Cancer 56:35-8. 2011
  4. pmc Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
    PLoS ONE 9:e115869. 2014

Detail Information

Publications4

  1. pmc Survival trends and long-term toxicity in pediatric patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
    Sarcoma 2012:636405. 2012
    ..The overall improvement in survival may in part be attributed to improved supportive care allowing regimens to be administered to best advantage with higher tolerance of chemotherapy and therefore less chemotherapy-related toxicity...
  2. doi request reprint Age as prognostic factor in patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, 6500HB Nijmegen, The Netherlands
    Bone 49:1173-7. 2011
    ..No significant difference was seen between outcomes of patients aged 15-19 years treated at the pediatric or adult oncology department. In conclusion, younger patients have a significantly better outcome than older patients...
  3. doi request reprint Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Pediatr Blood Cancer 56:35-8. 2011
    ..However, this material generally has been decalcified and formalin-fixed for many years. In our study, we investigated whether DNA obtained from these tissues can be used for reliable single nucleotide polymorphism (SNP) genotyping...
  4. pmc Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
    PLoS ONE 9:e115869. 2014
    ..With this largest meta-analysis performed to date, we show that the influence of TPMT and COMT on the development of cisplatin-induced hearing loss may be less important than previously suggested. ..